Roth Capital Downgrades VNUS Medical Technologies (VNUS) to Hold
VNUS Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 7 | New: 18
Roth Capital downgrades VNUS Medical Technologies (Nasdaq: VNUS) from Buy to Hold. Price target $29.
To see more analyst ratings on VNUS Click Here.
VNUS Medical Technologies, Inc. develops, manufactures and licenses products used in the minimally invasive treatment of venous reflux disease, including disposable endovenous catheters and radio-frequency (RF) generators.
To see more analyst ratings on VNUS Click Here.
VNUS Medical Technologies, Inc. develops, manufactures and licenses products used in the minimally invasive treatment of venous reflux disease, including disposable endovenous catheters and radio-frequency (RF) generators.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Wedbush Downgrades Maxwell Technologies (MXWL) to Neutral; Elevated Competitive and Supply Chain Risks
- Nomura Securities Maintains a 'Neutral' on Tiffany & Co. (TIF); Cutting Estimates and Price Target
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
